TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Location: France, Ile-de-France, Paris
Employees: 51-200
Total raised: $164.68M
Founded date: 2013
Investors 8
Funding Rounds 4
| Date | Series | Amount | Investors |
| 23.05.2023 | Series D | $54.11M | - |
| 01.09.2021 | Series C | $59.17M | - |
| 01.10.2020 | - | $8.2M | - |
| 26.11.2019 | Series B | $43.2M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 23.05.2023 | French medtech startup TISSIUM bags €50M to transform tissue... | Paris-based TISSIUM, a medtech company developing biomorphic programmable polymers for tissue recons... | siliconcan... |
| 23.05.2023 | Tissium Raises $50M in Series D Funding | Tissium, a Paris, France and Boston, MA-based medtech company developing biomorphic programmable pol... | finsmes.co... |
| 23.05.2023 | Paris-based TISSIUM raises €50 million in Series D round to ... | - | eu-startup... |
| 01.09.2021 | Medtech startup Tissium pockets €50M Series C | Paris-based Tissium has raised €50 million in a round led by Cathay Capital and Sofinnova Partners. ... | pitchbook.... |
| 31.08.2021 | Tissium Raises €50M in Series C Financing | Tissium, a Paris, France- and Boston, MA-based medtech company developing biomorphic programmable po... | finsmes.co... |
| 31.08.2021 | Databricks CEO on why Morgan Stanley is leading its new roun... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 31.08.2021 | Here’s how French medtech Tissium uses biopolymers for tissu... | Paris-based Tissium, a privately-owned medtech company that develops biomorphic programmable polymer... | siliconcan... |
| 31.08.2021 | TISSIUM Raises €50M in Series C Financing to Propel its Plat... | Paris, France, August 31, 2021 – TISSIUM, a privately-owned medtech company developing biomorphic pr... | cathaycapi... |
| 31.08.2021 | Paris-based TISSIUM raises €50 million to revolutionize the ... | Tissium co-founders, Maria Pereira and Christophe Bancel TISSIUM, a medtech company working on tissu... | eu-startup... |
| 31.08.2021 | Databricks CEO on why Morgan Stanley is leading its new roun... | There’s plenty of talk at this time in fundraising about venture capitalists winning deals by offeri... | fortune.co... |
Show more